Ep. 253, Chapter 1: Mark Eisner, MD & Vir Biotechnology

00:00 – 14:19

Chief Editor of Life Science Leader and Host of The Business of Biotech, Ben Comer, and EVP and CMO at Vir Technology, Mark Eisner, MD, discuss Eisner’s career transition from academic medicine to product development and now his role at Vir. Dr. Eisner elaborates on Vir's strategic pivot to prioritize hepatitis programs and acquire Sanofi's masked T-cell engager platform. He also shares his leadership philosophy, which emphasizes patient focus and colleague mentorship in a collaborative biotech environment.